Sensible Biotechnologies
A platform for designing and manufacturing naturally modified mRNA medicines.
$47MSeries A
ParticipantIC
Isomer Capital
Activity from announced rounds
Activity in this selectionnrw-venture-f5757e51
- Rounds participated in
- 2
- Confirmed lead rounds
- 0 1 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $107M 2 disclosed · full round size, not this investor’s share